CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
MindTrailsbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05126862
NCT05126862N/ACompleted
CompareCT.gov

Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)

University of Virginia·interventional·Posted Nov 19, 2021·Updated Dec 20, 2024

In Brief

A clinical study evaluating MindTrails for Huntington Disease and Parkinson Disease. Completed, enrolled 43 participants across 1 site.

Detailed Summary

The purpose of this study is conduct a pilot open trial of a web-based cognitive bias modification intervention to reduce anxiety symptoms in persons with Huntington's disease and persons with Parkinson's disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHuntington Disease, Parkinson Disease
CountriesUnited States
CollaboratorsNational Center for Advancing Translational Sciences (NCATS)

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 19, 2021
Enrollment StartDec 10, 2021
Primary CompletionJul 9, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.6 years ago

Interventions

MindTrailsbehavioral

MindTrails is a web-based cognitive bias modification intervention. Training sessions are designed to encourage cognitive flexibility through repeated practice assigning benign resolutions to ambiguous, anxiety-provoking situations.